NCT04519372View on ClinicalTrials.gov

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

CompletedOBSERVATIONAL
Enrollment

4,099

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 14, 2020

Study Completion Date

March 31, 2021

Conditions
Covid19SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Testing for SARS-CoV-2

All Patients admitted to the hospital were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.

Trial Locations (1)

4031

University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04519372 - SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting | Biotech Hunter | Biotech Hunter